精准肝切除治疗原发性肝癌的疗效评价

目的 初步探讨精准肝切除治疗原发性肝癌的疗效.方法 将2007年7月至2009年10月南京大学医学院附属鼓楼医院103例原发性肝癌患者根据不同肝切除方式分为精准组(54例)和常规组(49例).比较两组患者的术中、术后和随访情况.计量资料采用t检验,方差不齐采用t'检验,计数资料采用Fisher确切概率法进行分析.结果 两组患者均无围手术期死亡.精准组和常规组术中失血量分别为(635±608)ml和(929±1044)ml,两组比较差异无统计学意义(t=1.722,P>0.05);术中输血量分别为(222±381)ml和(542±785)ml,两组比较筹异有统计学意义(t=2.590,P<0.05);术后AST分别为(158±121)U/L和(292±347)U/L,两组比较差异有统计学意义(t=2.558,P<0.05);肿瘤标本切缘阳性率分别为2%(1/54)和18%(9/49),两组比较差异有统计学意义(P<0.05);术后并发症发生率分别为7%(4/54)和24%(12/49),两组比较差异有统计学意义(P<0.05);术后1年肿瘤复发率分别为24%(8/33)和42%(20/48);术后1年生存率分别为85%(28/33)和77%(37/48),两组预后比较差异无统计学意义(P>0.05).结论 肝癌患者在准确的术前评估后采用精准肝切除,手术打击较小,术后恢复更快,具有较好的疗效.

Evaluation of precise hepatectomy for primary liver cancer

Objective To evaluate the therapeutic effect and safety of precise hepatectomy for primary liver cancer.nethods A total of 103 liver cancer patients who had been admitted to Drum Tower Hospital from July 2007 to October 2009 were divided into precise hepatectomy group(n=54)and routine hepatectomy group (n=49).Peri-and postoperative conditions and the results of follow-up of patients in the 2 groups were compared.All data were analyzed via t test or Fisher exact test.Results No perioperative mortality was observed in the 2 groups.Mean blood loss was(635±608)ml in precise hepatectomy group and(929±1044)ml in routine hepatectomy group,with no significant difference between the 2 groups(t=1.722,P>0.05).Intraoperative blood transfusion volume,postoperative level of aspartate transaminase,positive rate of resection margin and incidence of postoperative complications were(222±381)ml,(158±121)U/L,2%(1/54)and 7%(4/54)in precise hepatectomy group,and were(542±785)ml,(292±347)U/L,18%(9/49)and 24%(12/49)in routine hepatectomy group,with significant difference between the 2 groups(t=2.590,2.558,P<0.05).The 1-year tumor recurrence rate and 1-year survival were 24%(8/33)and 85%(28/33)in precise hepatectomy group,42%(20/48)and 77%(37/48)in routine hepatectomy group,with no significant difference(P>0.05).Conclusion Precise hepatectomy is safe and effective in the treatment of liver caner without much injury to patients.